Published in Oncogene on December 04, 2003
Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy. Oncogene (2010) 1.67
Viruses associated with human cancer. Biochim Biophys Acta (2007) 1.47
Retracted Molecular characterization of Legionella pneumophila-induced interleukin-8 expression in T cells. BMC Microbiol (2010) 1.46
Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity. Retrovirology (2004) 1.32
MicroRNAs and human retroviruses. Biochim Biophys Acta (2011) 1.23
Ubiquitination of human T-cell leukemia virus type 1 tax modulates its activity. J Virol (2004) 1.22
Ubiquitin-specific peptidase 20 targets TRAF6 and human T cell leukemia virus type 1 tax to negatively regulate NF-kappaB signaling. J Virol (2011) 1.21
Dimerization of the I kappa B kinase-binding domain of NEMO is required for tumor necrosis factor alpha-induced NF-kappa B activity. Mol Cell Biol (2006) 1.10
HTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches. Apoptosis (2008) 0.99
Peptidylproline cis-trans-isomerase Pin1 interacts with human T-cell leukemia virus type 1 tax and modulates its activation of NF-kappaB. J Virol (2009) 0.97
HTLV-I tax increases genetic instability by inducing DNA double strand breaks during DNA replication and switching repair to NHEJ. PLoS One (2012) 0.92
Evidence for NF-kappaB- and CBP-independent repression of p53's transcriptional activity by human T-cell leukemia virus type 1 Tax in mouse embryo and primary human fibroblasts. J Virol (2005) 0.92
Retracted Helicobacter pylori induces CCL20 expression. Infect Immun (2007) 0.90
Oral administration of an HSP90 inhibitor, 17-DMAG, intervenes tumor-cell infiltration into multiple organs and improves survival period for ATL model mice. Blood Cancer J (2013) 0.88
Antitumor activity and macrophage nitric oxide producing action of medicinal herb, Crassocephalum crepidioides. BMC Complement Altern Med (2012) 0.88
Wip1 and p53 contribute to HTLV-1 Tax-induced tumorigenesis. Retrovirology (2012) 0.87
Mechanisms of Legionella pneumophila-induced interleukin-8 expression in human lung epithelial cells. BMC Microbiol (2007) 0.85
The zinc finger domain of IKKγ (NEMO) protein in health and disease. J Cell Mol Med (2010) 0.85
Commensal microbiota contributes to chronic endocarditis in TAX1BP1 deficient mice. PLoS One (2013) 0.82
Anti-apoptotic effect of Tax: an NF-κB path or a CREB way? Viruses (2011) 0.79
Evidence for cooperative transforming activity of the human pituitary tumor transforming gene and human T-cell leukemia virus type 1 Tax. J Virol (2007) 0.78
Induction of CD69 expression by cagPAI-positive Helicobacter pylori infection. World J Gastroenterol (2011) 0.77
Cotranscriptional Chromatin Remodeling by Small RNA Species: An HTLV-1 Perspective. Leuk Res Treatment (2012) 0.76
Development of ultra-super sensitive immunohistochemistry and its application to the etiological study of adult T-cell leukemia/lymphoma. Acta Histochem Cytochem (2012) 0.76
Human T cell leukemia virus type I tax-induced IκB-ζ modulates tax-dependent and tax-independent gene expression in T cells. Neoplasia (2013) 0.75
Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science (2007) 5.07
Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer (2007) 4.69
Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc Natl Acad Sci U S A (2007) 4.04
Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell (2004) 3.73
Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity (2005) 3.70
Crystal structure of the tetrameric Mad1-Mad2 core complex: implications of a 'safety belt' binding mechanism for the spindle checkpoint. EMBO J (2002) 3.42
Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene (2005) 2.96
Impact factor, H index, peer comparisons, and Retrovirology: is it time to individualize citation metrics? Retrovirology (2007) 2.87
A genome-wide short hairpin RNA screening of jurkat T-cells for human proteins contributing to productive HIV-1 replication. J Biol Chem (2009) 2.40
HIV-1 encoded candidate micro-RNAs and their cellular targets. Retrovirology (2004) 2.23
Accumulation of the inner nuclear envelope protein Sun1 is pathogenic in progeric and dystrophic laminopathies. Cell (2012) 2.18
Heterozygous deletion of mitotic arrest-deficient protein 1 (MAD1) increases the incidence of tumors in mice. Cancer Res (2007) 1.96
MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individuals. Retrovirology (2008) 1.96
Changes in microRNA expression profiles in HIV-1-transfected human cells. Retrovirology (2005) 1.95
Inflammatory cardiac valvulitis in TAX1BP1-deficient mice through selective NF-kappaB activation. EMBO J (2008) 1.87
Human cellular restriction factors that target HIV-1 replication. BMC Med (2009) 1.86
A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter. Nat Cell Biol (2003) 1.82
Pyrosequencing of small non-coding RNAs in HIV-1 infected cells: evidence for the processing of a viral-cellular double-stranded RNA hybrid. Nucleic Acids Res (2009) 1.69
The roles of microRNAs in mammalian virus infection. Biochim Biophys Acta (2008) 1.64
Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1. Cancer Res (2008) 1.63
Viral and cellular RNA helicases as antiviral targets. Nat Rev Drug Discov (2005) 1.59
Vaccinia virus vaccines: past, present and future. Antiviral Res (2009) 1.58
NEAT1 long noncoding RNA and paraspeckle bodies modulate HIV-1 posttranscriptional expression. MBio (2013) 1.55
HIV-1 TAR RNA subverts RNA interference in transfected cells through sequestration of TAR RNA-binding protein, TRBP. J Biol Chem (2006) 1.35
Physical interaction of human T-cell leukemia virus type 1 Tax with cyclin-dependent kinase 4 stimulates the phosphorylation of retinoblastoma protein. Mol Cell Biol (2002) 1.34
RISCy business: MicroRNAs, pathogenesis, and viruses. J Biol Chem (2007) 1.32
Transcriptional and post-transcriptional regulation of HIV-1 gene expression: role of cellular factors for Tat and Rev. Future Microbiol (2006) 1.32
Histone acetyltransferase hALP and nuclear membrane protein hsSUN1 function in de-condensation of mitotic chromosomes. J Biol Chem (2007) 1.31
Requirement for Sun1 in the expression of meiotic reproductive genes and piRNA. Development (2009) 1.30
FAT10 plays a role in the regulation of chromosomal stability. J Biol Chem (2006) 1.28
Differential acetylation of Tat coordinates its interaction with the co-activators cyclin T1 and PCAF. EMBO J (2002) 1.27
HTLV-1 Tax and adult T-cell leukemia. Front Biosci (2007) 1.25
Human T-lymphotropic virus type I tax activates I-kappa B kinase by inhibiting I-kappa B kinase-associated serine/threonine protein phosphatase 2A. J Biol Chem (2002) 1.25
Abnormal centrosome amplification in cells through the targeting of Ran-binding protein-1 by the human T cell leukemia virus type-1 Tax oncoprotein. Proc Natl Acad Sci U S A (2005) 1.24
Deoxynucleic acids from Cryptococcus neoformans activate myeloid dendritic cells via a TLR9-dependent pathway. J Immunol (2008) 1.24
MicroRNAs and human retroviruses. Biochim Biophys Acta (2011) 1.23
Prevalent loss of mitotic spindle checkpoint in adult T-cell leukemia confers resistance to microtubule inhibitors. J Biol Chem (2001) 1.23
The LINC complex is essential for hearing. J Clin Invest (2013) 1.22
Ubiquitination of human T-cell leukemia virus type 1 tax modulates its activity. J Virol (2004) 1.22
Ubiquitin-specific peptidase 20 targets TRAF6 and human T cell leukemia virus type 1 tax to negatively regulate NF-kappaB signaling. J Virol (2011) 1.21
H-index, mentoring-index, highly-cited and highly-accessed: how to evaluate scientists? Retrovirology (2008) 1.20
HIV-1 Tat interaction with Dicer: requirement for RNA. Retrovirology (2006) 1.20
Identification of small molecules that suppress microRNA function and reverse tumorigenesis. J Biol Chem (2010) 1.19
Tat and trans-activation-responsive (TAR) RNA-independent induction of HIV-1 long terminal repeat by human and murine cyclin T1 requires Sp1. J Biol Chem (2002) 1.19
Ring expanded nucleoside analogues inhibit RNA helicase and intracellular human immunodeficiency virus type 1 replication. J Med Chem (2008) 1.17
25 years of HIV-1 research - progress and perspectives. BMC Med (2008) 1.17
Role for Akt/protein kinase B and activator protein-1 in cellular proliferation induced by the human T-cell leukemia virus type 1 tax oncoprotein. J Biol Chem (2006) 1.17
TORC1 and TORC2 coactivators are required for tax activation of the human T-cell leukemia virus type 1 long terminal repeats. J Virol (2006) 1.17
Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBFβ interaction. Proc Natl Acad Sci U S A (2012) 1.16
Aneuploidy and cancer. J Cell Biochem (2007) 1.16
Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectors. PLoS One (2011) 1.16
Multiple NF-κB sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance. J Biol Chem (2012) 1.16
MicroRNAs and HIV-1: complex interactions. J Biol Chem (2012) 1.13
Spindle assembly checkpoint and p53 deficiencies cooperate for tumorigenesis in mice. Int J Cancer (2009) 1.12
Small non-coding RNAs, mammalian cells, and viruses: regulatory interactions? Retrovirology (2007) 1.12
Modulation of nuclear factor-kappaB by human T cell leukemia virus type 1 Tax protein: implications for oncogenesis and inflammation. Immunol Res (2006) 1.12
Discovery of a small molecule Tat-trans-activation-responsive RNA antagonist that potently inhibits human immunodeficiency virus-1 replication. J Biol Chem (2003) 1.11
The 2008 Retrovirology Prize: Ben Berkhout and his RNA world. Retrovirology (2008) 1.10
Differential requirements for activation of integrated and transiently transfected human T-cell leukemia virus type 1 long terminal repeat. J Virol (2002) 1.10
Retrovirology and young Turks... Retrovirology (2004) 1.09
An in vivo replication-important function in the second coding exon of Tat is constrained against mutation despite cytotoxic T lymphocyte selection. J Biol Chem (2003) 1.09
Human T-cell lymphotropic virus type 1 tax inhibits transforming growth factor-beta signaling by blocking the association of Smad proteins with Smad-binding element. J Biol Chem (2002) 1.09
Human immunodeficiency virus type 1 Vpr interacts with antiapoptotic mitochondrial protein HAX-1. J Virol (2005) 1.08
Proteomic identification of differentially-expressed genes in human gastric carcinomas. Proteomics (2005) 1.07
Genome-wide screening using RNA interference to study host factors in viral replication and pathogenesis. Exp Biol Med (Maywood) (2011) 1.07
Libya, HIV, and open communication. Retrovirology (2006) 1.07
Human T-cell leukemia virus oncoprotein tax represses nuclear receptor-dependent transcription by targeting coactivator TAX1BP1. Cancer Res (2007) 1.07
MicroRNA silencing of tumor suppressor DLC-1 promotes efficient hepatitis C virus replication in primary human hepatocytes. Hepatology (2010) 1.07
The young, not-so-young, and the 2007 Retrovirology Prize: call for nominations. Retrovirology (2007) 1.06
Host restriction factors in retroviral infection: promises in virus-host interaction. Retrovirology (2012) 1.05
Dectin-1 is not required for the host defense to Cryptococcus neoformans. Microbiol Immunol (2007) 1.05
Matrin 3 is a co-factor for HIV-1 Rev in regulating post-transcriptional viral gene expression. Retrovirology (2011) 1.04
Human T-cell leukemia virus type 1 Tax and cellular transformation. Int J Hematol (2007) 1.04
Limited contribution of Toll-like receptor 2 and 4 to the host response to a fungal infectious pathogen, Cryptococcus neoformans. FEMS Immunol Med Microbiol (2006) 1.03
Expression of a protein phosphatase 1 inhibitor, cdNIPP1, increases CDK9 threonine 186 phosphorylation and inhibits HIV-1 transcription. J Biol Chem (2010) 1.02
The retroviral oncoprotein Tax targets the coiled-coil centrosomal protein TAX1BP2 to induce centrosome overduplication. Nat Cell Biol (2006) 1.02
Inactivation of hTERT transcription by Tax. Oncogene (2003) 1.01
Human immunodeficiency virus type 1 replication and regulation of APOBEC3G by peptidyl prolyl isomerase Pin1. J Virol (2008) 1.00
Trimethylguanosine capping selectively promotes expression of Rev-dependent HIV-1 RNAs. Proc Natl Acad Sci U S A (2010) 0.99
Specific TATAA and bZIP requirements suggest that HTLV-I Tax has transcriptional activity subsequent to the assembly of an initiation complex. Retrovirology (2004) 0.98
Effects of valproate on Tax and HBZ expression in HTLV-1 and HAM/TSP T lymphocytes. Blood (2011) 0.98
Long non-coding RNAs (lncRNAs) and viral infections. Biomed Pharmacother (2013) 0.98
Characterization of regions in hsMAD1 needed for binding hsMAD2. A polymorphic change in an hsMAD1 leucine zipper affects MAD1-MAD2 interaction and spindle checkpoint function. J Biol Chem (2002) 0.98